KR20180016291A - 자가발포형 화장료 조성물 및 그 제조 방법 - Google Patents
자가발포형 화장료 조성물 및 그 제조 방법 Download PDFInfo
- Publication number
- KR20180016291A KR20180016291A KR1020170097766A KR20170097766A KR20180016291A KR 20180016291 A KR20180016291 A KR 20180016291A KR 1020170097766 A KR1020170097766 A KR 1020170097766A KR 20170097766 A KR20170097766 A KR 20170097766A KR 20180016291 A KR20180016291 A KR 20180016291A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- self
- skin
- weight
- group
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 249
- 239000002537 cosmetic Substances 0.000 title claims abstract description 160
- 238000005187 foaming Methods 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims description 23
- 150000002222 fluorine compounds Chemical class 0.000 claims abstract description 38
- 239000004094 surface-active agent Substances 0.000 claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 31
- 239000003921 oil Substances 0.000 claims description 33
- 235000019198 oils Nutrition 0.000 claims description 33
- 239000004480 active ingredient Substances 0.000 claims description 30
- 239000002736 nonionic surfactant Substances 0.000 claims description 23
- -1 polyoxyethylene Polymers 0.000 claims description 23
- 239000003945 anionic surfactant Substances 0.000 claims description 18
- 210000004209 hair Anatomy 0.000 claims description 18
- 229920005862 polyol Polymers 0.000 claims description 17
- 150000003077 polyols Chemical class 0.000 claims description 17
- 210000004761 scalp Anatomy 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000002562 thickening agent Substances 0.000 claims description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 12
- 229940008099 dimethicone Drugs 0.000 claims description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- DJXNLVJQMJNEMN-UHFFFAOYSA-N 2-[difluoro(methoxy)methyl]-1,1,1,2,3,3,3-heptafluoropropane Chemical compound COC(F)(F)C(F)(C(F)(F)F)C(F)(F)F DJXNLVJQMJNEMN-UHFFFAOYSA-N 0.000 claims description 4
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 4
- 235000001950 Elaeis guineensis Nutrition 0.000 claims description 4
- 229940073499 decyl glucoside Drugs 0.000 claims description 4
- 229930182478 glucoside Natural products 0.000 claims description 4
- 229940075529 glyceryl stearate Drugs 0.000 claims description 4
- 229940104872 methyl perfluoroisobutyl ether Drugs 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 4
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 2
- OKIYQFLILPKULA-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxybutane Chemical compound COC(F)(F)C(F)(F)C(F)(F)C(F)(F)F OKIYQFLILPKULA-UHFFFAOYSA-N 0.000 claims description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 2
- DFUYAWQUODQGFF-UHFFFAOYSA-N 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane Chemical compound CCOC(F)(F)C(F)(F)C(F)(F)C(F)(F)F DFUYAWQUODQGFF-UHFFFAOYSA-N 0.000 claims description 2
- SQEGLLMNIBLLNQ-UHFFFAOYSA-N 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane Chemical compound CCOC(F)(F)C(F)(C(F)(F)F)C(F)(F)F SQEGLLMNIBLLNQ-UHFFFAOYSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- PBFGMXZRJIUGKU-UHFFFAOYSA-N 3-decanoyloxybutyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCC PBFGMXZRJIUGKU-UHFFFAOYSA-N 0.000 claims description 2
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- BETABUADBFSHKC-UHFFFAOYSA-N 7-methyloctyl pyridine-4-carboxylate Chemical compound C(C1=CC=NC=C1)(=O)OCCCCCCC(C)C BETABUADBFSHKC-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 claims description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 229940048053 acrylate Drugs 0.000 claims description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims description 2
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 2
- 229940114374 butylene glycol dicaprylate Drugs 0.000 claims description 2
- 229940083979 caprylyl glucoside Drugs 0.000 claims description 2
- 229940086555 cyclomethicone Drugs 0.000 claims description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 229940045180 ethyl perfluoroisobutyl ether Drugs 0.000 claims description 2
- 229940100463 hexyl laurate Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 claims description 2
- 229940048848 lauryl glucoside Drugs 0.000 claims description 2
- 229940104873 methyl perfluorobutyl ether Drugs 0.000 claims description 2
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 claims description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 2
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 claims description 2
- 229940055577 oleyl alcohol Drugs 0.000 claims description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 2
- 239000003346 palm kernel oil Substances 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 229960004624 perflexane Drugs 0.000 claims description 2
- 229950011087 perflunafene Drugs 0.000 claims description 2
- UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 claims description 2
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 claims description 2
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 2
- 229940047670 sodium acrylate Drugs 0.000 claims description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 2
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 claims description 2
- 241000512897 Elaeis Species 0.000 claims 2
- 229940043375 1,5-pentanediol Drugs 0.000 claims 1
- LJOWJEKZXSHAQH-UHFFFAOYSA-N 2-methylpentane-3,3-diol Chemical compound CCC(O)(O)C(C)C LJOWJEKZXSHAQH-UHFFFAOYSA-N 0.000 claims 1
- SKVCWXRLKHBEKW-UHFFFAOYSA-N 2-methylpropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(C)C SKVCWXRLKHBEKW-UHFFFAOYSA-N 0.000 claims 1
- AISCBZKHUSXEOC-UHFFFAOYSA-N 3-Methyl-3-butenyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCC(C)C AISCBZKHUSXEOC-UHFFFAOYSA-N 0.000 claims 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 229940080421 coco glucoside Drugs 0.000 claims 1
- 229940071160 cocoate Drugs 0.000 claims 1
- FPDXMWHJGOCDQJ-HZAMXZRMSA-N ethyl (4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCC(=O)OCC)[C@@]2(C)[C@@H](O)C1 FPDXMWHJGOCDQJ-HZAMXZRMSA-N 0.000 claims 1
- 229940074928 isopropyl myristate Drugs 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- NCDCLPBOMHPFCV-UHFFFAOYSA-N n-hexyl n-hexanoate Natural products CCCCCCOC(=O)CCCCC NCDCLPBOMHPFCV-UHFFFAOYSA-N 0.000 claims 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims 1
- 229920000223 polyglycerol Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920001451 polypropylene glycol Polymers 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229940068965 polysorbates Drugs 0.000 claims 1
- 229940100515 sorbitan Drugs 0.000 claims 1
- 229950011392 sorbitan stearate Drugs 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 210000003491 skin Anatomy 0.000 description 120
- 238000012360 testing method Methods 0.000 description 34
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 24
- 239000000047 product Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 19
- 238000002156 mixing Methods 0.000 description 18
- 239000012071 phase Substances 0.000 description 14
- 229920002545 silicone oil Polymers 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 229960000271 arbutin Drugs 0.000 description 12
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 12
- 230000037384 skin absorption Effects 0.000 description 12
- 231100000274 skin absorption Toxicity 0.000 description 12
- 230000002087 whitening effect Effects 0.000 description 11
- 206010040880 Skin irritation Diseases 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 230000036556 skin irritation Effects 0.000 description 10
- 231100000475 skin irritation Toxicity 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000001816 cooling Methods 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- 230000035699 permeability Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 230000036548 skin texture Effects 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 229940100573 methylpropanediol Drugs 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 240000003133 Elaeis guineensis Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 208000016252 change in skin color Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- LVQSCKUKDKAQGO-UHFFFAOYSA-L disodium;diiodide Chemical compound [Na+].[Na+].[I-].[I-] LVQSCKUKDKAQGO-UHFFFAOYSA-L 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 229930194270 alpha-Vitamin Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940071124 cocoyl glutamate Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 208000019000 darkening of skin Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 description 1
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000003741 hair volume Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 1
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 229940061571 peg-9 dimethicone Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 229940078492 ppg-17 Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 1
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 239000008340 white lotion Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physics & Mathematics (AREA)
- Geometry (AREA)
- Cosmetics (AREA)
Abstract
Description
도 2는 일 실시예에 따른 자가발포형 조성물의 피부 적용시의 버블 생성 시간 및 버블 소멸 시간을 보여주는 사진이다.
구분 | 원료명 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예5 | 비교예1 | |
1 | 용제 | 정제수 | TO 100 | TO 100 | TO 100 | TO 100 | TO 100 | TO 100 |
2 | 이온 봉쇄제 | 디소듐이디티에이 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
3 | 폴리올 | 부틸렌글라이콜 | 4.00 | 6.00 | - | - | - | - |
메틸프로판디올 | - | - | 4.00 | 6.00 | 3.00 | 3.00 | ||
글리세린 | 2.00 | 3.00 | 4.00 | 3.00 | 5.00 | 5.00 | ||
4 | 점증제 | 카보머 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
잔탄검 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | ||
5 | 유화제(계면활성제) | 폴리글리세릴-10디스테아레이트 | 0.90 | 1.20 | 1.00 | 0.60 | 0.80 | 0.80 |
피이지-100스테아레이트 | 0.60 | 0.90 | 0.80 | 1.00 | 1.20 | 1.20 | ||
데실-글루코사이드 | 0.50 | 0.80 | 0.60 | 0.80 | 0.90 | 0.90 | ||
6 | 유화 안정제 | 세테아릴알코올 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
7 | pH조절제 | 포타슘하이드록사이드 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
8 | 피부컨디셔닝제 (오일) | 카프릴릭/카프릭트리글리세라이드 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
사이클로펜타실록산 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | ||
9 | 불소 화합물 | 메틸퍼플루오로이소부틸에테르 | 2.00 | 4.00 | 6.00 | 8.00 | 10.00 | - |
평가항목 | 패널 | 평균 | |||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||
흡수력 | 5 | 5 | 5 | 4 | 3 | 4 | 4 | 4 | 5 | 5 | 4.4 |
진정/수렴효과 | 5 | 5 | 5 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 4.4 |
끈적임 | 4 | 5 | 4 | 5 | 4 | 5 | 3 | 4 | 4 | 3 | 4.1 |
촉촉함 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 3 | 4 | 4.1 |
발림성 | 4 | 4 | 5 | 4 | 5 | 5 | 5 | 4 | 3 | 4 | 4.3 |
피부자극도 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 |
전체적인 만족도 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 5 | 4 | 4.4 |
평가항목 | 패널 | 평균 | |||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||
흡수력 | 3 | 2 | 4 | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 2.6 |
진정/수렴효과 | 4 | 3 | 3 | 3 | 2 | 4 | 3 | 3 | 3 | 3 | 3.1 |
끈적임 | 3 | 4 | 4 | 3 | 3 | 4 | 4 | 3 | 3 | 4 | 3.5 |
촉촉함 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3.4 |
발림성 | 3 | 2 | 4 | 3 | 3 | 4 | 3 | 3 | 4 | 4 | 3.3 |
피부자극도 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0.5 |
전체적인 만족도 | 3.4 | 2.8 | 3.6 | 3.0 | 2.8 | 3.8 | 3.4 | 3.2 | 3.4 | 3.6 | 3.3 |
구분 | 원료명 | 실시예6 | 실시예7 | 비교예2 | |
1 | 용제 | 정제수 | TO 100 | TO 100 | TO 100 |
2 | 이온 봉쇄제 | 디소듐이디티에이 | 0.02 | 0.02 | 0.02 |
3 | 폴리올 | 부틸렌글라이콜 | - | - | - |
메칠프로판디올 | 3.00 | 3.00 | 3.00 | ||
글리세린 | 5.00 | 5.00 | 5.00 | ||
4 | 점증제 | 카보머 | 0.25 | 0.25 | 0.25 |
잔탄검 | 0.15 | 0.15 | 0.15 | ||
5 | 유화제(계면활성제) | 폴리글리세릴-10디스테아레이트 | 0.80 | 0.80 | 0.80 |
피이지-100스테아레이트 | 1.20 | 1.20 | 1.20 | ||
데실-글루코사이드 | 0.90 | 0.90 | 0.90 | ||
6 | 유화 안정제 | 세테아릴알코올 | 1.00 | 1.00 | 1.00 |
7 | pH조절제 | 포타슘하이드록사이드 | 0.06 | 0.06 | 0.06 |
8 | 피부컨디셔닝제 | 카프릴릭/카프릭트리글리세라이드 | 2.00 | 2.00 | 2.00 |
사이클로펜타실록산 | 3.00 | 3.00 | 3.00 | ||
9 | 불소 화합물 | 메칠퍼플루오로이소부틸에텔 | 5.00 | 10.00 | 0.00 |
10 | 지표물질 | 알부틴 | 2.00 | 2.00 | 2.00 |
실시예6 | 실시예7 | 비교예2 | |
투과율(%) | 0.99 | 1.23 | 0.15 |
피검자 | 피부색의 밝기변화(ΔL) | 숙련자의 객관적 평가 | 피검자의 주관적 평가 | |||
A 그룹 (실시예7) |
B 그룹 (비교예2) |
A 그룹 (실시예7) |
B 그룹 (비교예2) |
A 그룹 (실시예7) |
B 그룹 (비교예2) |
|
1 | 3.5 | 2.7 | 2 | 0 | 2 | 0 |
2 | 3.4 | 2.4 | 1 | 1 | 2 | 1 |
3 | 2.9 | 2.5 | 1 | 0 | 2 | 0 |
4 | 3.0 | 2.9 | 2 | 0 | 1 | 0 |
5 | 3.6 | 1.9 | 2 | 1 | 1 | 1 |
6 | 3.9 | 2.2 | 1 | 1 | 2 | 1 |
7 | 3.5 | 2.7 | 2 | 1 | 2 | 1 |
8 | 3.2 | 2.6 | 1 | 0 | 0 | 0 |
9 | 3.8 | 2.3 | 1 | 0 | 1 | 0 |
10 | 3.3 | 1.9 | 1 | 0 | 2 | 0 |
11 | 2.9 | 2.4 | 2 | 1 | 2 | 1 |
12 | 3.7 | 2.1 | 2 | 0 | 1 | 1 |
13 | 4.4 | 2.5 | 1 | 1 | 1 | 1 |
14 | 4.5 | 2.1 | 1 | 0 | 1 | 0 |
15 | 3.1 | 2.2 | 1 | 0 | 2 | 0 |
16 | 3.3 | 1.7 | 2 | 2 | 2 | 2 |
17 | 3.6 | 1.8 | 2 | 0 | 1 | 0 |
18 | 3.7 | 2.5 | 0 | 1 | 2 | 0 |
19 | 3.3 | 2.4 | 1 | 1 | 1 | 1 |
20 | 3.1 | 2.1 | 2 | 1 | 1 | 2 |
평균 | 3.485 | 2.295 | 1.4 | 0.55 | 1.45 | 0.6 |
사용직후 | 2주 사용 후 | 3주 사용 후 | ||
ΔL | 평균 | 1.32 | 0.75 | 0.93 |
표준편차 | 0.66 | 0.69 | 0.86 | |
개선율(%) | 2.12 | 1.21 | 1.49 |
응답률 (조사인원: 총 25명) | ||||||
사용 기간 |
항목 | 전혀 아니다 |
아니다 | 보통이다 | 그렇다 | 매우 그렇다 |
2주 | 피부톤이 밝아진 것 같다. | - | - | 16% | 76% | 8% |
색소침착이 옅어진 느낌이다. | - | 4% | 28% | 64% | 4% | |
피부에서 윤기가 나는 것 같다. | - | - | 28% | 64% | 8% | |
피부결이 매끈해진 것 같다. | - | - | 20% | 60% | 20% | |
3주 | 피부톤이 밝아진 것 같다. | - | 8% | 80% | 12% | - |
색소침착이 옅어진 느낌이다. | - | 4% | 24% | 68% | 4% | |
피부에서 윤기가 나는 것 같다. | - | - | 20% | 68% | 12% | |
피부결이 매끈해진 것 같다. | - | - | 4% | 72% | 24% | |
4주 | 피부톤이 밝아진 것 같다. | - | - | 8% | 60% | 32% |
색소침착이 옅어진 느낌이다. | - | - | 16% | 68% | 16% | |
피부에서 윤기가 나는 것 같다. | - | - | 16% | 56% | 28% | |
피부결이 매끈해진 것 같다. | - | - | 4% | 56% | 40% |
Claims (19)
- 불소 화합물 및 비이온 계면활성제를 포함하는, 자가발포형 화장료 조성물.
- 제1항에 있어서, 상기 비이온 계면활성제는 폴리옥시에틸렌계 계면활성제, 폴리글리세린계 계면활성제, 및 슈가 에스테르계 계면활성제로 이루어진 군에서 선택된 1종 이상인, 자가발포형 화장료 조성물.
- 제1항에 있어서, 상기 비이온 계면활성제는 폴리글리세릴-3메칠글루코오스디스테아레이트, 폴리글리세릴-디스테아레이트류, 하이드로제네이티드레시틴, 세테아릴올리베이트, 소르비탄올리베이트, PEG-스테아레이트류, 글리세릴스테아레이트, 글리세릴스테아레이트에스이, 데실글루코사이드, 코코-글루코사이드, 라우릴글루코사이드, 카프릴릴/카프릴글루코사이드, 아라키딜글루코사이드, C12-20 (직쇄 또는 분지형) 알킬 글루코사이드, 세테아릴글루코사이드, 세테아레스류, 스테아레스류, 올레일 알코올의 폴리에틸렌글리콜에테르, 메칠글루코스세스퀴스테아레이트, 소르비탄스테아레이트, 슈크로스코코에이트, 폴리소르베이트류, 소르비탄세스퀴올리에이트, 소르비탄올리베이트, 기름야자오일, 및 기름야자커넬오일로 이루어진 군에서 선택된 1종 이상인 자가발포형 화장료 조성물.
- 제1항에 있어서, 상기 비이온 계면활성제는 총 조성물 중량 기준으로 0.1 내지 10 중량%의 양으로 포함되는 것인, 자가발포형 화장료 조성물.
- 제1항에 있어서, 상기 불소화합물은 메틸퍼플루오로이소부틸에테르, 메틸퍼플루오로부틸에테르, 에틸퍼플루오로부틸에테르, 에틸퍼플루오로이소부틸에테르, 퍼플루오로데칼린, 및 퍼플루오로헥산으로 이루어진 군에서 선택된 1종 이상인, 자가발포형 화장료 조성물.
- 제1항에 있어서, 상기 불소 화합물은 총 조성물 중량 기준으로 0.1 내지 20 중량%의 양으로 포함되는 것인, 자가발포형 화장료 조성물.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 불소 화합물과 비이온 계면활성제의 함량비는 중량 기준으로 1:0.2 내지 1.2(불소 화합물 중량:비이온 계면활성제 중량)인, 자가발포형 화장료 조성물.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 음이온성 계면활성제를 2중량% 이하로 포함하는 것을 특징으로 하는, 자가발포형 화장료 조성물.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 세정용 조성물이 아닌 것을 특징으로 하는, 자가발포형 화장료 조성물.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 오일, 폴리올, 및 점증제로 이루어진 군에서 선택된 1종 이상을 추가로 포함하는, 자가발포형 화장료 조성물.
- 제10항에 있어서, 상기 오일은 사이클로펜타실록산, 디메치콘, 디메치콘올, 사이클로메치콘, 트리실록산, 아모디메치콘, 페닐트리메치콘, 디실록산, 사이클로헥사실록산, PEG-디메치콘류, 폴리실리콘류, 시메치콘, 디페닐디메치콘, PEG-9폴리디메칠실록시에칠디메치콘, 카프릴릭/카프릭트리글리세라이드, 부틸렌글라이콜디카프릴레이트/디카프레이트, 하이드로제네이티드폴리이소부텐, 이소프로필미리스테이트, 세틸에칠틸헥사노에이트, 하이드로제네이티드폴리데센, 디에톡시에칠틸석시네이트, 헥실라우레이트, 트리에칠틸헥사노인, 이소노닐이소노나노에이트, 및 폴리이소부텐으로 이루어진 군에서 선택된 1종 이상인, 자가발포형 화장료 조성물.
- 제10항에 있어서, 상기 오일은 총 조성물 중량 기준으로 0.01 내지 10 중량%의 양으로 포함되는 것인, 자가발포형 화장료 조성물.
- 제10항에 있어서, 상기 폴리올은 부틸렌글라이콜, 글리세린, 글리세레스, 메칠틸프로판디올, PEG/PPG 코폴리머류, 메칠틸글루세스류, 디프로필렌글라이콜, 프로필렌글라이콜, 프로판디올, 및 카프릴릴글라이콜, 펜틸렌글라이콜로 이루어진 군에서 선택된 1종 이상인, 자가발포형 화장료 조성물.
- 제10항에 있어서, 상기 폴리올은 총 조성물 중량 기준으로 0.1 내지 20 중량%의 양으로 포함되는 것인, 자가발포형 화장료 조성물.
- 제10항에 있어서, 상기 점증제는 카보머, 암모늄아크릴로일디메칠틸타우레이트/브이피코폴리머, 잔탄검, 소듐폴리아크릴레이트, 하이드록시에칠틸셀룰로오스, 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머, 소듐폴리아크릴레이트, 소듐아크릴레이트/소듐아크릴로일디메칠틸타우레이트코폴리머, 마그네슘알루미늄실리케이트, 및 소듐카보머로 이루어진 군에서 선택된 1종 이상인, 자가발포형 화장료 조성물.
- 제10항에 있어서, 피부, 모발 또는 두피 케어 효과를 갖는 활성성분을 추가로 포함하는, 자가발포형 화장료 조성물.
- 제11항에 있어서, 피부, 모발 또는 두피 케어 효과를 갖는 활성성분을 추가로 포함하는, 자가발포형 화장료 조성물.
- 제1항 내지 6항 중 어느 한 항의 자가발포형 화장료 조성물을 포함하는 피부, 모발 또는 두피 케어용 제품.
- 제10항의 자가발포형 화장료 조성물을 포함하는 피부, 모발 또는 두피 케어용 제품.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160100326 | 2016-08-05 | ||
KR20160100326 | 2016-08-05 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190032573A Division KR102080290B1 (ko) | 2016-08-05 | 2019-03-21 | 자가발포형 화장료 조성물 및 그 제조 방법 |
Publications (3)
Publication Number | Publication Date |
---|---|
KR20180016291A true KR20180016291A (ko) | 2018-02-14 |
KR101962952B1 KR101962952B1 (ko) | 2019-03-27 |
KR101962952B9 KR101962952B9 (ko) | 2023-12-15 |
Family
ID=61073494
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170097766A KR101962952B1 (ko) | 2016-08-05 | 2017-08-01 | 자가발포형 화장료 조성물 및 그 제조 방법 |
KR1020190032573A KR102080290B1 (ko) | 2016-08-05 | 2019-03-21 | 자가발포형 화장료 조성물 및 그 제조 방법 |
KR1020190130278A KR102216005B1 (ko) | 2016-08-05 | 2019-10-18 | 자가발포형 화장료 조성물 및 그 제조 방법 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190032573A KR102080290B1 (ko) | 2016-08-05 | 2019-03-21 | 자가발포형 화장료 조성물 및 그 제조 방법 |
KR1020190130278A KR102216005B1 (ko) | 2016-08-05 | 2019-10-18 | 자가발포형 화장료 조성물 및 그 제조 방법 |
Country Status (3)
Country | Link |
---|---|
KR (3) | KR101962952B1 (ko) |
CN (1) | CN109843250B (ko) |
WO (1) | WO2018026171A1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190105383A (ko) | 2018-03-05 | 2019-09-17 | 코스맥스 주식회사 | 자가발포 기능을 갖는 화장료 조성물 |
KR20200029255A (ko) * | 2018-09-10 | 2020-03-18 | 주식회사 코리아나화장품 | 모발의 건조 시간 감소 및 유연감 개선 효과를 갖는 모발 화장료 조성물 |
KR20200105033A (ko) | 2019-02-28 | 2020-09-07 | 주식회사 맥클린코스메틱 | 펩타이드 볼륨 에센스 |
KR102234579B1 (ko) * | 2020-12-07 | 2021-03-31 | 리봄화장품 주식회사 | 버블 필오프 팩 화장료 조성물 및 그 제조방법 |
KR102561767B1 (ko) * | 2022-12-27 | 2023-08-02 | (주)비에프글로벌 | 다래나무 수액을 포함하는 화장료 조성물 및 이의 제조방법 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108852945B (zh) * | 2018-09-14 | 2021-06-15 | 广州艾蓓生物科技有限公司 | 一种自发泡的氨基酸洁面乳 |
KR20220135537A (ko) | 2021-03-30 | 2022-10-07 | 주식회사 코스메카코리아 | 자가 발포 기능을 가지는 정제 형태의 세정용 화장료 조성물 |
CN116769266B (zh) * | 2023-07-13 | 2024-01-23 | 上海芯密科技有限公司 | 一种半导体密封圈橡胶材料及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008189644A (ja) * | 2007-02-01 | 2008-08-21 | Supplement Co Ltd | 自己発泡可能な皮膚清浄剤組成物 |
KR20120039396A (ko) * | 2010-10-15 | 2012-04-25 | 네비온 주식회사 | 불소화합물을 함유하는 화장료 조성물 및 그의 제조방법 |
KR20150082791A (ko) * | 2014-01-08 | 2015-07-16 | 코웨이 주식회사 | 다기능 클렌징 화장료 조성물 |
KR20150108611A (ko) * | 2014-03-18 | 2015-09-30 | 주식회사 한국화장품제조 | 자가 발포 기능을 갖는 클렌징용 마스크시트형 화장료 및 그 제조 방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2795633A1 (fr) * | 1999-06-30 | 2001-01-05 | Oreal | Utilisation dans une composition cosmetique demaquillante ou nettoyante d'au moins un compose fluore volatil |
CN101744743A (zh) | 2008-11-28 | 2010-06-23 | 高宝化妆品(中国)有限公司 | 一种自发泡洁肤面膜及其制作方法 |
KR20120039241A (ko) * | 2010-10-15 | 2012-04-25 | 코스맥스 주식회사 | 휘발성 불소화합물을 함유하는 내용물을 안전하게 보관하는 라미네이트 튜브 |
JP6083993B2 (ja) * | 2012-09-07 | 2017-02-22 | ノーベル化学宏業株式会社 | 発泡性の1剤式二酸化炭素外用剤 |
KR20140094187A (ko) * | 2013-01-21 | 2014-07-30 | 코웨이 주식회사 | 계면활성제를 포함하지 않는 자가발포성 화장료 조성물 |
CN104688621A (zh) | 2015-03-02 | 2015-06-10 | 上海卡卡化妆品有限公司 | 一种自发泡化妆品组合物及其制备方法 |
-
2017
- 2017-08-01 WO PCT/KR2017/008299 patent/WO2018026171A1/ko active Application Filing
- 2017-08-01 KR KR1020170097766A patent/KR101962952B1/ko active IP Right Review Request
- 2017-08-01 CN CN201780062082.4A patent/CN109843250B/zh active Active
-
2019
- 2019-03-21 KR KR1020190032573A patent/KR102080290B1/ko active IP Right Review Request
- 2019-10-18 KR KR1020190130278A patent/KR102216005B1/ko active IP Right Review Request
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008189644A (ja) * | 2007-02-01 | 2008-08-21 | Supplement Co Ltd | 自己発泡可能な皮膚清浄剤組成物 |
KR20120039396A (ko) * | 2010-10-15 | 2012-04-25 | 네비온 주식회사 | 불소화합물을 함유하는 화장료 조성물 및 그의 제조방법 |
KR20150082791A (ko) * | 2014-01-08 | 2015-07-16 | 코웨이 주식회사 | 다기능 클렌징 화장료 조성물 |
KR20150108611A (ko) * | 2014-03-18 | 2015-09-30 | 주식회사 한국화장품제조 | 자가 발포 기능을 갖는 클렌징용 마스크시트형 화장료 및 그 제조 방법 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190105383A (ko) | 2018-03-05 | 2019-09-17 | 코스맥스 주식회사 | 자가발포 기능을 갖는 화장료 조성물 |
KR20200029255A (ko) * | 2018-09-10 | 2020-03-18 | 주식회사 코리아나화장품 | 모발의 건조 시간 감소 및 유연감 개선 효과를 갖는 모발 화장료 조성물 |
KR20200105033A (ko) | 2019-02-28 | 2020-09-07 | 주식회사 맥클린코스메틱 | 펩타이드 볼륨 에센스 |
KR102234579B1 (ko) * | 2020-12-07 | 2021-03-31 | 리봄화장품 주식회사 | 버블 필오프 팩 화장료 조성물 및 그 제조방법 |
KR102561767B1 (ko) * | 2022-12-27 | 2023-08-02 | (주)비에프글로벌 | 다래나무 수액을 포함하는 화장료 조성물 및 이의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR101962952B9 (ko) | 2023-12-15 |
KR101962952B1 (ko) | 2019-03-27 |
KR20190034510A (ko) | 2019-04-02 |
CN109843250A (zh) | 2019-06-04 |
KR20190122612A (ko) | 2019-10-30 |
KR102216005B1 (ko) | 2021-02-16 |
KR102080290B1 (ko) | 2020-02-21 |
WO2018026171A1 (ko) | 2018-02-08 |
CN109843250B (zh) | 2023-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101962952B1 (ko) | 자가발포형 화장료 조성물 및 그 제조 방법 | |
JP6843863B2 (ja) | (ポリ)グリセロールの少なくとも2つの脂肪酸エステルを含む組成物、および化粧品におけるその使用 | |
CA2690716C (en) | Infused sponge delivery system | |
CA2900091C (en) | Cosmetic product comprising uv-blocking cosmetic composition impregnated into expanded urethane foam | |
KR101655346B1 (ko) | 고유상 안정화 화장료 조성물 | |
MXPA06012192A (es) | Composiciones para el cuidado personal que depositan agentes beneficos hidrofilos. | |
MXPA06012179A (es) | Composiciones para el cuidado personal que depositan agentes beneficos hidrofilos. | |
JPH04193814A (ja) | 透明ないし半透明の化粧料 | |
KR20120065982A (ko) | 발포 우레탄 폼에 함침시켜 제조하는 자외선 차단 화장료 조성물 | |
US20130345317A1 (en) | Water-releasing cosmetic composition including a hydrophobic silica and a co-emulsifier | |
KR102043485B1 (ko) | 수중유형 유화조성물 | |
KR101338518B1 (ko) | 유중수형 보습화장료 조성물 | |
KR20160065658A (ko) | 유화제를 함유하지 않는 워셔블 클렌징 화장료 조성물 | |
KR101590803B1 (ko) | 칼라민을 포함하는 즉각미백 또는 안색개선용 화장료 조성물 | |
JP3614511B2 (ja) | 日焼け止め用水中油型乳化化粧料 | |
KR101719174B1 (ko) | 라멜라 액정이 수분산된 실리콘 중 수(w/s) 타입 유화 조성물 및 이의 용도 | |
KR102432885B1 (ko) | 안티에이징 화장료 조성물 | |
KR102537397B1 (ko) | 리포좀 및 이를 포함하는 화장료 조성물 | |
KR102040490B1 (ko) | 피부 쿨링 및 보습 효과가 우수한 화장료 조성물 | |
KR20130042918A (ko) | 피부 유수분 밸런스 유지용 조성물 및 이를 포함하는 화장료 조성물 | |
JP2017081883A (ja) | 皮膚外用剤 | |
KR20090056390A (ko) | 자외선차단제를 포함하는 다층상 화장료 조성물 | |
KR102310519B1 (ko) | 탄산가스 포집용 에어로졸 조성물 | |
JP2019077675A (ja) | ジェル状皮膚外用剤又は皮膚化粧料 | |
EP1093800B1 (en) | Cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
Z031 | Request for patent cancellation [new post grant opposition system introduced on 1 march 2017] | ||
J204 | Request for invalidation trial [patent] | ||
J121 | Written withdrawal of request for trial | ||
Z031 | Request for patent cancellation [new post grant opposition system introduced on 1 march 2017] | ||
J204 | Request for invalidation trial [patent] | ||
Z031 | Request for patent cancellation [new post grant opposition system introduced on 1 march 2017] | ||
Z072 | Maintenance of patent after cancellation proceedings: certified copy of decision transmitted [new post grant opposition system as of 20170301] | ||
Z131 | Decision taken on request for patent cancellation [new post grant opposition system as of 20170301] | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2019100002290; TRIAL DECISION FOR INVALIDATION REQUESTED 20190716 Effective date: 20201130 |
|
J2X1 | Appeal (before the patent court) |
Free format text: TRIAL NUMBER: 2020200007722; INVALIDATION |
|
J204 | Request for invalidation trial [patent] | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2021100000614; TRIAL DECISION FOR INVALIDATION REQUESTED 20210226 Effective date: 20220928 |
|
J302 | Written judgement (patent court) |
Free format text: TRIAL NUMBER: 2022200005799; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20221126 Effective date: 20230623 |
|
J303 | Written judgement (supreme court) |
Free format text: TRIAL NUMBER: 2023300010804; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20230731 Effective date: 20231116 |